润都股份：坎地沙坦酯片获得药品注册证书

Core Viewpoint - The company has received a drug registration certificate for Candesartan Cilexetil Tablets from the National Medical Products Administration, indicating a significant regulatory approval for a new hypertension treatment [1] Group 1: Company Information - The drug is named Candesartan Cilexetil Tablets, with a dosage form of tablets and a specification of 16mg [1] - The registration classification of the drug is categorized as a Class 4 chemical drug [1] Group 2: Industry Relevance - The drug is indicated for the treatment of primary hypertension, which is a significant area in the pharmaceutical industry given the prevalence of hypertension globally [1]